These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Overexpression of mammaglobin B in epithelial ovarian carcinomas. Tassi RA; Bignotti E; Rossi E; Falchetti M; Donzelli C; Calza S; Ravaggi A; Bandiera E; Pecorelli S; Santin AD Gynecol Oncol; 2007 Jun; 105(3):578-85. PubMed ID: 17343903 [TBL] [Abstract][Full Text] [Related]
3. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Jones MB; Krutzsch H; Shu H; Zhao Y; Liotta LA; Kohn EC; Petricoin EF Proteomics; 2002 Jan; 2(1):76-84. PubMed ID: 11788994 [TBL] [Abstract][Full Text] [Related]
4. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038 [TBL] [Abstract][Full Text] [Related]
5. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer. Garg M; Chaurasiya D; Rana R; Jagadish N; Kanojia D; Dudha N; Kamran N; Salhan S; Bhatnagar A; Suri S; Gupta A; Suri A Clin Cancer Res; 2007 Mar; 13(5):1421-8. PubMed ID: 17332284 [TBL] [Abstract][Full Text] [Related]
6. The granulin-epithelin precursor/PC-cell-derived growth factor is a growth factor for epithelial ovarian cancer. Jones MB; Michener CM; Blanchette JO; Kuznetsov VA; Raffeld M; Serrero G; Emmert-Buck MR; Petricoin EF; Krizman DB; Liotta LA; Kohn EC Clin Cancer Res; 2003 Jan; 9(1):44-51. PubMed ID: 12538450 [TBL] [Abstract][Full Text] [Related]
7. Microarray expression identification of differentially expressed genes in serous epithelial ovarian cancer compared with bulk normal ovarian tissue and ovarian surface scrapings. Grisaru D; Hauspy J; Prasad M; Albert M; Murphy KJ; Covens A; Macgregor PF; Rosen B Oncol Rep; 2007 Dec; 18(6):1347-56. PubMed ID: 17982616 [TBL] [Abstract][Full Text] [Related]
8. Expression analysis and RNA localization of PAI-RBP1 (SERBP1) in epithelial ovarian cancer: association with tumor progression. Koensgen D; Mustea A; Klaman I; Sun P; Zafrakas M; Lichtenegger W; Denkert C; Dahl E; Sehouli J Gynecol Oncol; 2007 Nov; 107(2):266-73. PubMed ID: 17698176 [TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor alpha, amphiregulin and cripto-1 are frequently expressed in advanced human ovarian carcinomas. D'Antonio A; Losito S; Pignata S; Grassi M; Perrone F; De Luca A; Tambaro R; Bianco C; Gullick WJ; Johnson GR; Iaffaioli VR; Salomon DS; Normanno N Int J Oncol; 2002 Nov; 21(5):941-8. PubMed ID: 12370739 [TBL] [Abstract][Full Text] [Related]
11. Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy. Haram KM; Peltier HJ; Lu B; Bhasin M; Otu HH; Choy B; Regan M; Libermann TA; Latham GJ; Sanda MG; Arredouani MS Prostate; 2008 Oct; 68(14):1517-30. PubMed ID: 18668517 [TBL] [Abstract][Full Text] [Related]
12. Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression. Rangel LB; Sherman-Baust CA; Wernyj RP; Schwartz DR; Cho KR; Morin PJ Oncogene; 2003 Oct; 22(46):7225-32. PubMed ID: 14562052 [TBL] [Abstract][Full Text] [Related]
13. [Screening and identification of ovarian carcinomas related genes]. Yue W; Sun LY; Li CH; Zhang LX; Pei XT Ai Zheng; 2004 Feb; 23(2):141-5. PubMed ID: 14960231 [TBL] [Abstract][Full Text] [Related]
14. Differential gene expression profiling of laryngeal squamous cell carcinoma by laser capture microdissection and complementary DNA microarrays. Ma LJ; Li W; Zhang X; Huang DH; Zhang H; Xiao JY; Tian YQ Arch Med Res; 2009 Feb; 40(2):114-23. PubMed ID: 19237021 [TBL] [Abstract][Full Text] [Related]
15. Large-scale proteomics analysis of human ovarian cancer for biomarkers. Bengtsson S; Krogh M; Szigyarto CA; Uhlen M; Schedvins K; Silfverswärd C; Linder S; Auer G; Alaiya A; James P J Proteome Res; 2007 Apr; 6(4):1440-50. PubMed ID: 17315909 [TBL] [Abstract][Full Text] [Related]
16. Transcriptomic analysis of an in vitro murine model of ovarian carcinoma: functional similarity to the human disease and identification of prospective tumoral markers and targets. Urzúa U; Roby KF; Gangi LM; Cherry JM; Powell JI; Munroe DJ J Cell Physiol; 2006 Mar; 206(3):594-602. PubMed ID: 16245302 [TBL] [Abstract][Full Text] [Related]
17. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Resnick KE; Alder H; Hagan JP; Richardson DL; Croce CM; Cohn DE Gynecol Oncol; 2009 Jan; 112(1):55-9. PubMed ID: 18954897 [TBL] [Abstract][Full Text] [Related]
18. Clinical validity of the lung cancer biomarkers identified by bioinformatics analysis of public expression data. Kim B; Lee HJ; Choi HY; Shin Y; Nam S; Seo G; Son DS; Jo J; Kim J; Lee J; Kim J; Kim K; Lee S Cancer Res; 2007 Aug; 67(15):7431-8. PubMed ID: 17671213 [TBL] [Abstract][Full Text] [Related]
19. The reduction in pigment epithelium-derived factor is a sign of malignancy in ovarian cancer expressing low-level of vascular endothelial growth factor. Tsuchiya T; Nakahama K; Asakawa Y; Maemura T; Tanaka M; Takeda S; Morita M; Morita I Gynecol Endocrinol; 2009 Feb; 25(2):104-9. PubMed ID: 19253105 [TBL] [Abstract][Full Text] [Related]
20. BTF4/BTNA3.2 and GCS as candidate mRNA prognostic markers in epithelial ovarian cancer. Le Page C; Ouellet V; Quinn MC; Tonin PN; Provencher DM; Mes-Masson AM Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):913-20. PubMed ID: 18398031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]